Upstate Active Clinical Trials
Study Title:
Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlledadaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke
What is the purpose of the study? (in Layman's terms, please describe the study)
The MOST study is designed to find out whether adding one of two blood-thinning medicines (argatroban or eptifibatide) to standard treatment helps to decrease the impact of strokes and is safe. Earlier studies have shown that it seems safe and may be helpful to add argatroban or eptifibatide to tPA (standard treatment) to help dissolve clots causing stroke.Upstate Institutional Review Board (IRB) Number:
1344888Study Phase:
N/APatient Age Group:
AdultsPrincipal Investigator:
Julius Gene S LatorreWho can I contact for more information?
Name: Lena F Deb
Phone: 315-464-9756
Email: debl@upstate.edu